AAAAAA

   
Results: 1-16 |
Results: 16

Authors: Havrilesky, LJ McMahon, CP Lobenhofer, EK Whitaker, R Marks, JR Berchuck, A
Citation: Lj. Havrilesky et al., Relationship between expression of coactivators and corepressors of hormone receptors and resistance of ovarian cancers to growth regulation by steroid hormones, J SOC GYN I, 8(2), 2001, pp. 104-113

Authors: West, M Blanchette, C Dressman, H Huang, E Ishida, S Spang, R Zuzan, H Olson, JA Marks, JR Nevins, JR
Citation: M. West et al., Predicting the clinical status of human breast cancer by using gene expression profiles, P NAS US, 98(20), 2001, pp. 11462-11467

Authors: Krop, IE Sgroi, D Porter, DA Lunetta, KL LeVangie, R Seth, P Kaelin, CM Rhei, E Bosenberg, M Schnitt, S Marks, JR Pagon, Z Belina, D Razumovic, J Polyak, K
Citation: Ie. Krop et al., HIN-1, a putative cytokine highly expressed in normal but not cancerous mammary epithelial cells, P NAS US, 98(17), 2001, pp. 9796-9801

Authors: Porter, DA Krop, IE Nasser, S Sgroi, D Kaelin, CM Marks, JR Riggins, G Polyak, K
Citation: Da. Porter et al., A SAGE (serial analysis of gene expression) view of breast tumor progression, CANCER RES, 61(15), 2001, pp. 5697-5702

Authors: Moorman, PG Hamza, A Marks, JR Olson, JA
Citation: Pg. Moorman et al., Prognostic significance of the number of lymph nodes examined in patients with lymph node-negative breast carcinoma, CANCER, 91(12), 2001, pp. 2258-2262

Authors: Lobenhofer, EK Huper, G Iglehart, JD Marks, JR
Citation: Ek. Lobenhofer et al., Inhibition of mitogen-activated protein kinase and phosphatidylinositol 3-kinase activity in MCF-7 cells prevents estrogen-induced mitogenesis, CELL GROWTH, 11(2), 2000, pp. 99-110

Authors: Lobenhofer, EK Marks, JR
Citation: Ek. Lobenhofer et Jr. Marks, Estrogen-induced mitogenesis of MCF-7 cells does not require the inductionof mitogen-activated protein kinase activity, J STEROID B, 75(1), 2000, pp. 11-20

Authors: Ferguson, AT Evron, E Umbricht, CB Pandita, TK Chan, TA Hermeking, H Marks, JR Lambers, AR Futreal, PA Stampfer, MR Sukumar, S
Citation: At. Ferguson et al., High frequency of hypermethylation at the 14-3-3 sigma locus leads to genesilencing in breast cancer, P NAS US, 97(11), 2000, pp. 6049-6054

Authors: Benoit, TG Locke, J Marks, JR Beasley, CW
Citation: Tg. Benoit et al., Laboratory transmission of Xanthomonas campestris pv Raphani by a tardigrade (Parachela = Macrobiotidae), FLA ENTOMOL, 83(2), 2000, pp. 197-199

Authors: Seth, P Lunetta, KL Bell, DW Gray, H Nasser, SM Rhei, E Kaelin, CM Iglehart, DJ Marks, JR Garber, JE Haber, DA Polyak, K
Citation: P. Seth et al., Phenol sulfotransferases: Hormonal regulation, polymorphism, and age of onset of breast cancer, CANCER RES, 60(24), 2000, pp. 6859-6863

Authors: Szukala, SA Marks, JR Burchette, JL Elbendary, AA Krigman, HR
Citation: Sa. Szukala et al., Co-expression of p53 by epithelial and stromal elements in carcinosarcoma of the female genital tract: an immunohistochemical study of 19 cases, INT J GYN C, 9(2), 1999, pp. 131-136

Authors: Davis, PL Miron, A Andersen, LM Iglehart, JD Marks, JR
Citation: Pl. Davis et al., Isolation and initial characterization of the BRCA2 promoter, ONCOGENE, 18(44), 1999, pp. 6000-6012

Authors: Berchuck, A Schildkraut, JM Marks, JR Futreal, PA
Citation: A. Berchuck et al., Managing hereditary ovarian cancer risk, CANCER, 86(8), 1999, pp. 1697-1704

Authors: Berchuck, A Schildkraut, JM Marks, JR Futreal, PA
Citation: A. Berchuck et al., Managing hereditary ovarian cancer risk, CANCER, 86(11), 1999, pp. 2517-2524

Authors: Lambers, AR Gumbs, C Ali, S Marks, JR Iglehart, JD Berchuck, A Futreal, PA
Citation: Ar. Lambers et al., Bcl10 is not a target for frequent mutation in human carcinomas, BR J CANC, 80(10), 1999, pp. 1575-1576

Authors: Lopez, CB Rao, TD Feiner, H Shapiro, R Marks, JR Frey, AB
Citation: Cb. Lopez et al., Repression of interleukin-2 mRNA translation in primary human breast carcinoma tumor-infiltrating lymphocytes, CELL IMMUN, 190(2), 1998, pp. 141-155
Risultati: 1-16 |